LAUSR

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment

Sign Up to like & get
recommendations!
2 Published in 2023 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2023.1052657

Abstract: Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of… read more here.

Keywords: checkpoint inhibitors; immune checkpoint; inhibitors potential; caxii inhibitors ... See more keywords